주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Women’s Brain Project

Aim & scope

The purpose of the series is to provide comprehensive references on different topics in basic/clinical research being conducted on the influence of sex and gender in brain and mental health and precision medicine research. Titles cover sex and gender differences in basic and clinical neuroscience, explore the role of such differences in disease management and clinical trials, consider sex and gender biases in digital medicine, and delve into how artificial intelligence could leverage sex differences for precision medicine.

The Women’s Brain Project (WBP) is an international non-profit organization advocating for women’s brain and mental health. Founded in 2016, the WBP is a group of scientists hailing from various disciplines including medicine, neuroscience, psychology, pharmacology and communication who work together with caregivers, patients and their relatives, policymakers and other stakeholders. The WBP aims to stimulate a global discussion on gender and sex determinants of female vulnerability to brain and mental disease.

Women’s Brain Project

They propose a new, personalized way to develop and perform medical treatments, caregiving and prevention strategies together with novel technologies development, based on consideration of sex and gender differences. By promoting a scientific discussion on the specific vulnerability of the female brain to particular mental and brain diseases, WBP advocates for the development of sex- specific measures to foster mental health. They address these issues through publishing and promoting scientific research, debate, public engagement and advocacy. They host biennial scientific forums that foster an interdisciplinary discussion with patients, caregivers, regulators, policymakers, industry, artificial intelligence experts and academic scientists on the role of sex and gender in the management and treatment of brain and mental diseases.

Clinical and basic researchers, clinicians and advanced medical students in the fields of neurodegeneration, neuroscience, neurology, neuropsychology and neuropharmacology, biomedicine, and healthcare.

Audience

Clinical and basic researchers, clinicians and advanced medical students in the fields of neurodegeneration, neuroscience, neurology, neuropsychology and neuropharmacology, biomedicine, and healthcare.

Editor

MTF

Maria Teresa Ferretti

Chief Scientific Officer

Group Leader, Institute of Regenerative Medicine

Maria Teresa Ferretti 더 읽어보기

ASD

Annemarie Schumacher Dimech

Program Manager

CAS Comprehensive Palliative Care, University of Lucerne, Switzerland

Annemarie Schumacher Dimech 더 읽어보기

ACS

Antonella Chadha Santuccione

Chief Executive Officer

Antonella Chadha Santuccione 더 읽어보기